ArticleScientific reports2026
Fine particulate matter exacerbates childhood asthma via DNMT3A-mediated modulation of GPX4 DNA methylation.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Fine particulate matter measuring less than 2.5 μm in diameter (PM(2.5)) is a significant risk factor for acute asthma episodes in children. Nevertheless, the biological mechanism that underpins this correlation remains unclear. Here, we found that PM(2.5)-induced inflammatory cell infiltration and aggravated childhood asthma in a ferroptosis-dependent manner. GPX4 overexpression could reverse the PM(2.5)-induced increase in reactive oxygen species (ROS), malondialdehyde (MDA), and inflammatory factors, as well as the decrease in mitochondrial membrane potential. Mechanistically, PM(2.5) elevated DNMT3A expression and hypermethylated the promoter region of GPX4, leading to reduced GPX4 expression and promoting ferroptosis. Furthermore, the status of GPX4 DNA methylation was significantly associated with IL-6/8 levels in mild/moderate and severe childhood asthma patients. In conclusion, our research highlights the critical interplay between PM(2.5) exposure, DNA methylation, and ferroptosis in asthma exacerbation, providing clues for the treatment of childhood asthma.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.